TY - JOUR
T1 - Using Mindfulness-Based Cognitive Therapy to Prevent Suicide Among High Suicide–Risk Patients Who Also Misuse Opioids
T2 - a Preliminary Probe of Feasibility and Effectiveness
AU - Chesin, Megan S.
AU - Dave, Chintan V.
AU - Myers, Catherine
AU - Stanley, Barbara
AU - Kline, Anna
AU - Monahan, Maureen
AU - Latorre, Miriam
AU - Hill, Lauren M.St
AU - Miller, Rachael B.
AU - King, Arlene R.
AU - Boschulte, Dianna R.
AU - Sedita, Megan
AU - Interian, Alejandro
N1 - Funding Information: This work was supported by a grant from the US Department of Veterans Affairs, Health Services Research and Development Service (IIR 12–134). Publisher Copyright: © 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2022
Y1 - 2022
N2 - Knowledge of how to effectively prevent suicide attempt (SA) in high suicide–risk patients who also misuse opioids is limited. In a subset of data from 36 participants with baseline opioid misuse in a randomized clinical trial testing adjunctive mindfulness-based cognitive therapy to prevent suicide among high suicide–risk veterans (n = 18 per treatment condition), MBCT-S reduced the likelihood of SA and acute psychiatric hospitalization over 12-month follow-up. Those in MBCT-S had a relative risk of 17% and 42% for SA and hospitalization (p =.09,.02), respectively, compared to those receiving enhanced treatment as usual (eTAU) alone. Rates of opioid misuse during follow-up were more than halved with the addition of MBCT-S to eTAU (p =.08). Meanwhile, among trial participants who did not misuse opioids (n = 104), RRs of 64% and 77% for SA and hospitalization (p =.28,.33), respectively, were found with MBCT-S compared to eTAU. An MBCT-S trial with greater power is warranted in this population.
AB - Knowledge of how to effectively prevent suicide attempt (SA) in high suicide–risk patients who also misuse opioids is limited. In a subset of data from 36 participants with baseline opioid misuse in a randomized clinical trial testing adjunctive mindfulness-based cognitive therapy to prevent suicide among high suicide–risk veterans (n = 18 per treatment condition), MBCT-S reduced the likelihood of SA and acute psychiatric hospitalization over 12-month follow-up. Those in MBCT-S had a relative risk of 17% and 42% for SA and hospitalization (p =.09,.02), respectively, compared to those receiving enhanced treatment as usual (eTAU) alone. Rates of opioid misuse during follow-up were more than halved with the addition of MBCT-S to eTAU (p =.08). Meanwhile, among trial participants who did not misuse opioids (n = 104), RRs of 64% and 77% for SA and hospitalization (p =.28,.33), respectively, were found with MBCT-S compared to eTAU. An MBCT-S trial with greater power is warranted in this population.
KW - High suicide–risk patients
KW - Mindfulness-based cognitive therapy to prevent suicide
KW - Opioid misuse
KW - Veterans
UR - http://www.scopus.com/inward/record.url?scp=85128390642&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85128390642&partnerID=8YFLogxK
U2 - https://doi.org/10.1007/s11469-022-00817-x
DO - https://doi.org/10.1007/s11469-022-00817-x
M3 - Article
SN - 1557-1874
JO - International Journal of Mental Health and Addiction
JF - International Journal of Mental Health and Addiction
ER -